|
The 2020-2021 Flu Season is coming to an end. This means that soon it will be time to return any expired flu vaccine. Here are some general reminders for flu returns.
- A return cannot be submitted and vaccines cannot be returned until after the expiration date.
- Returning flu vaccines is completed in the IIS, the same way you complete a return for regular childhood vaccines.
- Open multi-dose vials (MDVs) cannot be returned to McKesson. You will still submit a record of the expired vaccine in the IIS, but then dispose of that vaccine in clinic. There should be an option to select “Expired – Open MDV”.
- All flu order sets have now been removed from the IIS.
Resources:
Online Vaccine Returns Quick Reference Guide
How to Search, Add, Reconcile, and Report Inventory Guide
Vaxelis (DTaP-IPV-HIB-HepB) and MenQuadfi (meningococcal groups A, C, W, and Y polysaccharide tetanus toxoid conjugate vaccine (MenACWY-TT) will be available for ordering through the Childhood Vaccine Program starting on July 1. We will provide information about these new vaccines in this newsletter in upcoming weeks.
Summary of Vaxelis and MenQuadfi:
- Vaxelis is a combination of DTaP, IPV, Hib, Hep B vaccines and is licensed for children age 6 weeks through 4 years (before the 5th birthday). It is indicated as a 3-dose series for infants at ages 2, 4, and 6 months. Vaxelis may be used for children younger than age 5 years who are on a catch-up primary series. It is NOT approved as the booster dose of DTaP (dose 4 or dose 5) or Hib (dose 4). However, if Vaxelis is inadvertently given as a booster dose, it may count as valid and does not need to be repeated.
Vaxelis Resources:
- MenQuadfi is a new MenACWY conjugate vaccine (MenACWY-TT) approved in the US in April 2020 and is licensed for persons aged 2 years and older.
- MenQuadfi, Menactra, or Menveo can be used for adolescents who are routinely recommended to receive MenACWY vaccine at 11 or 12 years of age.
- MenQuadfi can be used for anyone who is at higher risk for meningococcal disease at 2 years and older, or you can use Menactra (9 months-55 years), or Menveo (2 months-55 years).
- MenQuadfi will eventually replace Menactra and Menactra will be phased out over the next year.
MenQuadfi Resources:
The American Academy of Pediatrics (AAP) offers a Childhood Immunization Flipchart designed to help clinicians in conversations with patients and families. The flipchart focuses on routine vaccinations for children from birth to age six years and contains family-friendly infographics and provider speaking points. There is no charge, as supplies last. Request copies of the flipcharts.
|
